Pathogenicity of Porcine Circovirus Type 2e in Experimentally Infected Pigs

Abstract

A new porcine circovirus type 2e (PCV2e) genotype was recently isolated from diseased pigs. To investigate the pathogenicity of PCV2e, groups of conventional pigs were inoculated in one of three ways: with PCV2e only, with Mycoplasma hyopneumoniae and PCV2e, or with PCV2e and porcine reproductive and respiratory syndrome virus (PRRSV). Pigs were examined post mortem at 21 days post inoculation. Pigs in the M. hyopeumoniae/PCV2e group were inoculated intratracheally with M. hyopneumoniae at 4 weeks of age followed by an intranasal inoculation with PCV2e at 6 weeks of age. Pigs in the PCV2e/PRRSV group were inoculated intranasally with PCV2e and PRRSV at 6 weeks of age. Significant differences in PCV2e loads in blood or lymph nodes, or in the severity of lymphoid lesions, were not detected between the M. hyopneumoniae/PCV2e and PCV2e/PRRSV groups. All pigs co-infected with either M. hyopneumoniae/PCV2e or PCV2e/PRRSV developed mild porcine circovirus-associated disease (PCVAD), whereas none of the pigs infected with PCV2e alone developed PCVAD. Production of PCVAD in pigs therefore appears to require PCV2e infection simultaneously with an additional infectious agent such as M. hyopneumoniae or PRRSV for full disease expression in pigs. These results demonstrate that PCV2e is not associated with significant clinical disease as assessed by levels of PCV2e viraemia and severity of lymphoid lesions.